| 查看: 803 | 回复: 0 | ||
[求助]
胃肠道和胰腺神经内分泌肿瘤细胞系的建立
|
|
在innocentive.com上看到的一个挑战项目,肠道类癌或胰腺神经内分泌肿瘤细胞系 Intestinal Carcinoid and Pancreatic Neuroendocrine Tumor Cell Lines Needed – Year Two 一直想做,截至7月6日,时间紧,不知有没有在自己胃肠道类癌或胰腺神经内分泌肿瘤细胞系的?一方面是推荐,一方面是有些新方法想找实验室合作。 BACKGROUND The majority of neuroendocrine tumors can be divided into two classes: carcinoid and pancreatic neuroendocrine tumors. Carcinoid commonly refers to neuroendocrine tumors that originate in the gastrointestinal (GI) tract, lungs, appendix and thymus, although they can also occur in the lymph nodes, brain, bone, gonads (ovaries and testes) and skin. Carcinoid tumors are usually indolent (slow-growing) by nature and develop over the course of many years. However, aggressive, fast-growing forms of carcinoid cancer also exist. Neuroendocrine tumors are classified as rare cancers. Recent studies have determined that 4 to 5 out of every 100,000 people are diagnosed yearly with a neuroendocrine tumor and that there are over 100,000 people currently living with neuroendocrine tumors within the United States (Yao et al., 2009). For reasons not well understood, the incidence of these cancers is rising. Since most individuals with neuroendocrine tumors are asymptomatic until the tumors metastasize, the average time between tumor development and diagnosis is between 5 to 10 years (Vinik, 2008; Vinik et al., 2009). Survival rates for individuals with neuroendocrine cancer vary and depend on tumor type, location, extent of metastases, and many other factors. Currently, surgery is the only cure for localized tumors (those which have not spread) and there is no cure for metastatic neuroendocrine cancer (Yao, 2007). This Challenge is intended to encourage development of intestinal carcinoid and pancreatic neuroendocrine tumor cell lines. 我的邮箱是:agilebio@126.com |
» 猜你喜欢
中了面上,感谢小本虫,这是我唯一的获取信息渠道。
已经有22人回复
26申博求推荐,生物医学工程/计算机视觉/医学图像目标检测与分割
已经有3人回复
地方病学/职业病学论文润色/翻译怎么收费?
已经有205人回复
26年考研
已经有12人回复
【CSC招生】荷兰莱顿大学医学中心LKEB图像处理实验室 招收2026年CSC博士生多名
已经有799人回复
西安交通大学生命学院智能化诊疗装备研究中心2026年博士生招生
已经有9人回复
湖南工业大学-生物医学工程-招收调剂
已经有0人回复
中山大学中山医学院 赵博教授课题组2027级学术型博士生招生
已经有5人回复
中山大学深圳校区博导招生:转化生长因子TGF-β功能性抗体开发
已经有0人回复










回复此楼